GlassScriptPhysician profile
Shantanu Warhadpande
NPI 1326497884
$2,681.23
in general payments reported to CMS, 2019-2025
9 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $617 · 2022: $986 · 2023: $570 · 2024: $387 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $592.40 | 2022-2023 | Alphavac, Angiovac |
| Stryker Corporation | $432.79 | 2022-2023 | Spinejack |
| Medtronic, INC. | $384.20 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Inari Medical, INC. | $278.11 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $242.74 | 2022-2024 | Indigo System |
| Cook Medical LLC | $237.41 | 2021 | |
| Terumo Medical Corporation | $204.92 | 2022-2025 | Azur Cx Detachable |
| W. L. Gore & Associates, INC. | $187.23 | 2021-2022 | |
| Cardiva Medical, INC. | $121.43 | 2024 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shantanu Warhadpande listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.